# Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)

> **NCT06160908** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 38 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DEVICE:** NirsCure
- **DEVICE:** sham NirsCure
- **DEVICE:** NirsCure

## Key facts

- **NCT ID:** NCT06160908
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-12
- **Primary completion:** 2024-08-25
- **Final completion:** 2028-06-30
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06160908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06160908, "Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06160908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*